Search results
Mar 18, 2023 · Dr. Andres Hurtado-Lorenzo - Precision Medicine in IBD Summit 2022. Leveraging multi-omics-based biomarkers to advance precision medicine for inflammatory bowel diseases (IBD) - Presented by...
- 25 min
- 113
- Andres Hurtado-Lorenzo
Oct 6, 2018 · Last month, Andres Hurtado-Lorenzo, Ph.D. Senior Director of Translational Research for the Crohn’s & Colitis Foundation, had an opportunity to present “Towards Precision Medicine in Inflammatory Bowel Diseases” at the 5th Precision Medicine and Biomarkers Leaders Summit in Munich.
Sep 11, 2023 · the ultimate goal of cure, preclinical human-relevant research is critical and must center on mechanistic. ents with IB. in the three areas of disease interception, remission, andrestoration. Gaps previously high. mechanisms included: (1) triggers of immune response, (2) intestinal epithelial homeostasis and wound.
ANDRÉS HURTADO-LORENZO, Ph.D. SENIOR DIRECTOR OF TRANSLATIONAL RESEARCH Precision Medicine and Biomarkers Leaders Summit. Munich September 13 - 14, 2018
Andres Hurtado-Lorenzo. Dr. Hurtado-Lorenzo is responsible for planning and oversight the Foundation’s translational research portfolio that is advancing solutions for patients based on research in the fields of Precision Medicine, Genetics, Microbiome, Biomarkers, and Biosensors.
As the Senior Vice President of Translational Research and IBD Ventures at the Crohn's & Colitis Foundation, I lead a scientific team that aims to identify and advance novel therapeutic and ...
- Crohn's & Colitis Foundation
Visionary and strategic scientific leader with over 20 years of experience translating… | Learn more about Andres Hurtado-Lorenzo, PhD's work experience, education, connections & more by ...
- 2K followers
